Global CAR T-Cell Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 CAR T-Cell Immunotherapy Market Overview

• 1.1 Product Overview and Scope of CAR T-Cell Immunotherapy
• 1.2 Classification of CAR T-Cell Immunotherapy by Types
  • 1.2.1 Global CAR T-Cell Immunotherapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Types in 2018
  • 1.2.3 Monotherapy
  • 1.2.4 Combination Therapy
• 1.3 Global CAR T-Cell Immunotherapy Market by Application
  • 1.3.1 Global CAR T-Cell Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hematologic Malignancies
  • 1.3.3 Solid Malignancies
• 1.4 Global CAR T-Cell Immunotherapy Market by Regions
  • 1.4.1 Global CAR T-Cell Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
• 1.5 Global Market Size of CAR T-Cell Immunotherapy (2014-2024)

2 Manufacturers Profiles

• 2.1 AbbVie
  • 2.1.1 Business Overview
  • 2.1.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Celgene
  • 2.2.1 Business Overview
  • 2.2.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Kite Pharma
  • 2.3.1 Business Overview
  • 2.3.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Oxford BioMedica
  • 2.4.1 Business Overview
  • 2.4.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Novartis
  • 2.5.1 Business Overview
  • 2.5.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Gilead
  • 2.6.1 Business Overview
  • 2.6.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Pfizer
  • 2.7.1 Business Overview
  • 2.7.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Cellectis
  • 2.8.1 Business Overview
  • 2.8.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Bellicum
  • 2.9.1 Business Overview
  • 2.9.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Mustang Bio
  • 2.10.1 Business Overview
  • 2.10.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 CARsgen Therapeutics
  • 2.11.1 Business Overview
  • 2.11.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Xyphos
  • 2.12.1 Business Overview
  • 2.12.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Minerva Biotechnologies
  • 2.13.1 Business Overview
  • 2.13.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Adaptimmune
  • 2.14.1 Business Overview
  • 2.14.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Ziopharm Oncology
  • 2.15.1 Business Overview
  • 2.15.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Aurora Biopharma
  • 2.16.1 Business Overview
  • 2.16.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Creative Biolabs
  • 2.17.1 Business Overview
  • 2.17.2 CAR T-Cell Immunotherapy Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global CAR T-Cell Immunotherapy Market Competition, by Players

• 3.1 Global CAR T-Cell Immunotherapy Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 CAR T-Cell Immunotherapy Players Market Share
  • 3.2.2 Top 10 CAR T-Cell Immunotherapy Players Market Share
• 3.3 Market Competition Trend

4 Global CAR T-Cell Immunotherapy Market Size by Regions

• 4.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions
• 4.2 North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.3 Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.5 South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)

5 North America CAR T-Cell Immunotherapy Revenue by Countries

• 5.1 North America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
• 5.2 USA CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 5.3 Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 5.4 Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)

6 Europe CAR T-Cell Immunotherapy Revenue by Countries

• 6.1 Europe CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
• 6.2 Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.3 UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.4 France CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.5 Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.6 Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries

• 7.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
• 7.2 China CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.3 Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.4 Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.5 India CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)

8 South America CAR T-Cell Immunotherapy Revenue by Countries

• 8.1 South America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
• 8.2 Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 8.3 Argentina CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 8.4 Colombia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue CAR T-Cell Immunotherapy by Countries

• 9.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.3 UAE CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.4 Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.6 South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)

10 Global CAR T-Cell Immunotherapy Market Segment by Type

• 10.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2014-2019)
• 10.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2019-2024)
• 10.3 Monotherapy Revenue Growth Rate (2014-2024)
• 10.4 Combination Therapy Revenue Growth Rate (2014-2024)

11 Global CAR T-Cell Immunotherapy Market Segment by Application

• 11.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2014-2019)
• 11.2 CAR T-Cell Immunotherapy Market Forecast by Application (2019-2024)
• 11.3 Hematologic Malignancies Revenue Growth (2014-2019)
• 11.4 Solid Malignancies Revenue Growth (2014-2019)

12 Global CAR T-Cell Immunotherapy Market Size Forecast (2019-2024)

• 12.1 Global CAR T-Cell Immunotherapy Market Size Forecast (2019-2024)
• 12.2 Global CAR T-Cell Immunotherapy Market Forecast by Regions (2019-2024)
• 12.3 North America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
• 12.4 Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
• 12.6 South America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology